Iterum Therapeutics PLC
NASDAQ:ITRM
Iterum Therapeutics PLC
NASDAQ:ITRM
Price:
1.61 USD
0.63%
Market Closed
Updated:
May 10, 2024
Iterum Therapeutics PLC
Operating Expenses
|
Iterum Therapeutics PLC
Operating Expenses Peer Comparison
Comparables:
PRGO
JAZZ
AVDL
G
GHRS
COPN
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Iterum Therapeutics PLC
NASDAQ:ITRM
|
Operating Expenses
-$47.5m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
Perrigo Company PLC
NYSE:PRGO
|
Operating Expenses
-$1.4B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-6%
|
|
|
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
|
Operating Expenses
-$2.9B
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-17%
|
|
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
Operating Expenses
-$165m
|
CAGR 3-Years
-43%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-12%
|
|
G
|
GH Research PLC
NASDAQ:GHRS
|
Operating Expenses
-$41.2m
|
CAGR 3-Years
-351%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cosmo Pharmaceuticals NV
SIX:COPN
|
Operating Expenses
-€45.2m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
6%
|
CAGR 10-Years
-6%
|
See Also
What is Iterum Therapeutics PLC's Operating Expenses?
Operating Expenses
-47.5m
USD
-47.5m
USD
Based on the financial report for Dec 31, 2023, Iterum Therapeutics PLC's Operating Expenses amounts to -47.5m USD.
What is Iterum Therapeutics PLC's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
9%
9%
Over the last year, the Operating Expenses growth was -56%. The average annual Operating Expenses growth rates for Iterum Therapeutics PLC have been -14% over the past three years , 9% over the past five years .
You don't have any saved screeners yet
